Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Servier Trial on Diabetes Drug Can Resume After Ruling, AFP Says

Aug. 24 (Bloomberg) -- The trial of Les Laboratoires Servier and its founder over allegations they hid risks linked to a diabetes drug can resume after an appeals court today refused to ask France’s constitutional court to review their challenge to the case, Agence France-Presse said today, citing lawyers involved in the matter.

A hearing has been set for December to reschedule the trial, which was suspended in May, AFP said.

To contact the reporter on this story: Heather Smith in Paris at

To contact the editor responsible for this story: Christopher Scinta at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.